TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 3 | -2 | -6 | -8 | -3 | -30 | -22 | -12 |
| S | %wins | 100 | 100 | 67 | 67 | 67 | 67 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/15 16:15 | 5/20/15 | GSB | Globalscape Inc | DE | Tech | Softw | Prepackaged Software | Renfro Phillip M | TX | D | S.d | -93 | 3.27 | 0 | -28 | -22 | 99 | D | 95 | 53 | 34 | -1 | -1 | 0 | -3 | -3 | -2 | -3 | 6 | 4 | 16 | 1 | |
5/13/08 17:06 | 5/12/08 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Renfro Phillip M | NJ | D | S.d | -142 | 9.49 | 6 | -15 | -100 | 0 | D | 8 | 15 | -5 | 13 | 1 | 3 | 3 | 2 | -4 | -6 | -15 | -5 | -53 | -34 | |
5/12/08 10:52 | 5/9/08 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Renfro Phillip M | NJ | D | S | -52 | 9.46 | 6 | -5 | -100 | 0 | D | 7 | 16 | -5 | 16 | 3 | 4 | 9 | 3 | 0 | -8 | -15 | -7 | -54 | -34 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |